JAK-1/PERK dual inhibitor (Mercachem)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameJAK-1/PERK dual inhibitor (Mercachem)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic Translation Initiation Factor 2 Alpha Kinase 3 inhibitorsTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK1Eukaryotic Translation Initiation Factor 2 Alpha Kinase 3
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMercachem Holding BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMercachem Holding BV
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A